Kursprognose für Abeona Therapeutics Inc (ABEO)ABEOAbeona Therapeutics Inc

Alphio's ABEO stock price prediction model matches the current Abeona Therapeutics Inc tape against historical breakout patterns, then publishes 1-day and 1-week targets first. The 1-day print is $4.42 (+0.55%). The 1-week path is $4.42 (+0.48%). Longer windows use the same pattern set plus seasonality; the 1-month and multi-year forecasts sit behind unlock because they include precise min / avg / max bands.

Abeona Therapeutics Inc (ABEO) appears to be a good buy right now due to its recent clinical advancements and positive analyst ratings. The current price is $4.40, significantly below the analyst price target of $17 from Roth Capital, implying a potential upside of 286%. Additionally, Cantor Fitzgerald's target of $30 suggests a potential upside of 582%. The company has activated its eighth clinical site for ZEVASKYN trials, which could drive future revenue growth. However, a notable risk is the company's negative earnings per share (EPS) of -0.35 reported last quarter, indicating ongoing financial challenges.

Abeona Therapeutics Inc (ABEO) last closed at $4.4, losing -1.57%. These facts feed the 1-day and 1-week ABEO price prediction above.